MSHLX
Price
$47.37
Change
+$1.12 (+2.42%)
Updated
May 13 closing price
Net Assets
4.16B
RGEBX
Price
$73.28
Change
+$0.23 (+0.31%)
Updated
May 14 closing price
Net Assets
299.96B
Ad is loading...

MSHLX vs RGEBX

Header iconMSHLX vs RGEBX Comparison
Open Charts MSHLX vs RGEBXBanner chart's image
Morgan Stanley Inst Growth L
Price$47.37
Change+$1.12 (+2.42%)
VolumeN/A
Net Assets4.16B
American Funds Growth Fund of Amer R2E
Price$73.28
Change+$0.23 (+0.31%)
VolumeN/A
Net Assets299.96B
MSHLX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSHLX vs. RGEBX commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSHLX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 300B vs. MSHLX (4.16B). MSHLX pays higher dividends than RGEBX: MSHLX (0.13) vs RGEBX (0.00). MSHLX was incepted earlier than RGEBX: MSHLX (13 years) vs RGEBX (11 years). MSHLX (1.37) is less costly to investors than RGEBX (1.09). MSHLX is a more actively managed with annual turnover of: 39.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSHLX: RGEBX (250) vs MSHLX (1000). MSHLX annual gain was more profitable for investors over the last year : 59.01 vs. RGEBX (7.51). RGEBX return over 5 years is better than : 49.39 vs. MSHLX (-11.95).
MSHLXRGEBXMSHLX / RGEBX
Total Expense Ratio1.371.09126%
Annual Report Gross Expense Ratio1.371.09126%
Fund Existence13 years11 years-
Gain YTD5.9562.576231%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.16B300B1%
Annual Yield % from dividends0.130.00-
Returns for 1 year59.017.51786%
Returns for 3 years53.3835.82149%
Returns for 5 years-11.9549.39-24%
Returns for 10 years13.9461.6623%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NLSP1.650.02
+1.22%
Nls Pharmaceutics Ltd
GDRX4.27-0.03
-0.70%
GoodRx Holdings
OVV38.98-0.36
-0.92%
Ovintiv
REPX28.56-0.91
-3.09%
Riley Exploration Permian
STIM4.30-0.14
-3.26%
Neuronetics